Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Centralized post-marketing safety monitoring of troxerutin and cerebroprotein injection in hospitalized patients
ChiCTR2000034875Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Henan University of Chinese Medicine
- Start
- Aug 2020
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of troxerutin + cerebroprotein, sponsored by First Affiliated Hospital of Henan University of Chinese Medicine. Primary endpoint: Incidence and types of adverse drug reactions/events (ADR/ADE). Planned start Aug 2020; status: not yet recruiting.
02
Drugs
troxerutin + cerebroprotein
Beyond the preview
Go deeper on ChiCTR2000034875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034875.